De Burlo Group’s Pfizer PFE Stock Holding History

De Burlo Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,320	Closed	-$503K	–	90
2023 Q1	$503K	Buy	12,320 +13	+0.1%	+$561	0.1%	78
2022 Q4	$631K	Hold	12,307	–	–	0.14%	65
2022 Q3	$539K	Buy	12,307 +3,267	+36%	+$159K	0.13%	66
2022 Q2	$474K	Sell	9,040 -3,967	-30%	-$202K	0.14%	41
2022 Q1	$673K	Sell	13,007 -256,700	-95%	-$13.3M	0.13%	67
2021 Q4	$15.9M	Buy	269,707 +164,700	+157%	+$8.16M	2.31%	13
2021 Q3	$4.52M	Buy	+105,007	New	+$4.65M	0.73%	42
2020 Q1	–	Sell	-5,486	Closed	-$204K	–	80
2019 Q4	$204K	Buy	+5,486	New	+$195K	0.04%	81
2019 Q3	–	Sell	-5,486	Closed	-$225K	–	89
2019 Q2	$225K	Hold	5,486	–	–	0.04%	82
2019 Q1	$221K	Sell	5,486 -791	-13%	-$31.7K	0.04%	91
2018 Q4	$259K	Buy	6,277 +51	+0.8%	+$2.12K	0.06%	87
2018 Q3	$260K	Hold	6,226	–	–	0.05%	106
2018 Q2	$214K	Hold	6,226	–	–	0.05%	103
2018 Q1	$209K	Hold	6,226	–	–	0.05%	100
2017 Q4	$213K	Sell	6,226 -1,107	-15%	-$37.7K	0.04%	103
2017 Q3	$248K	Hold	7,333	–	–	0.06%	102
2017 Q2	$233K	Buy	7,333 +2,899	+65%	+$91.4K	0.05%	99
2017 Q1	$143K	Buy	+4,434	New	+$140K	0.03%	99
2014 Q2	–	Sell	-6,595	Closed	-$201K	–	107
2014 Q1	$201K	Buy	+6,595	New	+$197K	0.05%	93

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

De Burlo Group's PFE Position: Q2 2023 in Review

De Burlo Group sold out of Pfizer (PFE) in Q2 2023, closing a stake of 12,320 shares — an estimated $503K sold.

De Burlo Group first reported a position in PFE in Q1 2014 and held it in 19 quarters. The position peaked at $15.9M in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

De Burlo Group reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
De Burlo Group sold 12,320 Pfizer shares in Q2 2023, an estimated $503K.
De Burlo Group first reported a position in Pfizer in Q1 2014 and held it in 19 quarters.
De Burlo Group's Pfizer position peaked at $15.9M in Q4 2021.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on De Burlo Group's 13F filing for Q2 2023, filed 14 Aug 2023.